Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024136
Filing Date
2021-06-16
Accepted
2021-06-16 16:20:10
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1608
2 EX-24 DOCUMENT attachment1.htm EX-24 3432
  Complete submission text file 0000899243-21-024136.txt   6519
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TYME TECHNOLOGIES, INC. 1 PLUCKEMIN WAY, SUITE 103 BEDMINSTER NJ 07921
Business Address
PORFIDO FRANK L. (Reporting) CIK: 0001866899 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38169 | Film No.: 211021748